Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
TDP1 protein | 3 | 0 | 0 | 3 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 0 | 0 | 1 |
Trypsin | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 1 | 3 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Histamine H2 receptor | 2 | 0 | 1 | 3 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Calmodulin | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 2 |
Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
thioredoxin reductase | 4 | 0 | 0 | 4 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
GLS protein | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 2 | 1 | 5 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 1 | 4 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 2 | 1 | 5 |
B1 bradykinin receptor | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
AR protein | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 3 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Prothrombin | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 3 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
General amino-acid permease GAP1 | 0 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
estrogen nuclear receptor alpha | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
geminin | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 4 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
Histamine H2 receptor | 0 | 1 | 2 | 3 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2C adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |